APA (7th ed.) Citation

K, H., R, S., S, R., MS, W., P, B., S, L., . . . JS, H. (2025). Phase 1 study of ABI-009 (nab-rapamycin) for surgically refractory epilepsy (RaSuRE). Epilepsia, 66(11), 4246. https://doi.org/10.1111/epi.18555

Chicago Style (17th ed.) Citation

K, Hall, et al. "Phase 1 Study of ABI-009 (nab-rapamycin) for Surgically Refractory Epilepsy (RaSuRE)." Epilepsia 66, no. 11 (2025): 4246. https://doi.org/10.1111/epi.18555.

MLA (9th ed.) Citation

K, Hall, et al. "Phase 1 Study of ABI-009 (nab-rapamycin) for Surgically Refractory Epilepsy (RaSuRE)." Epilepsia, vol. 66, no. 11, 2025, p. 4246, https://doi.org/10.1111/epi.18555.